CA2888811C - A diet package, and uses thereof - Google Patents

A diet package, and uses thereof Download PDF

Info

Publication number
CA2888811C
CA2888811C CA2888811A CA2888811A CA2888811C CA 2888811 C CA2888811 C CA 2888811C CA 2888811 A CA2888811 A CA 2888811A CA 2888811 A CA2888811 A CA 2888811A CA 2888811 C CA2888811 C CA 2888811C
Authority
CA
Canada
Prior art keywords
diet
days
day
mice
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2888811A
Other languages
English (en)
French (fr)
Other versions
CA2888811A1 (en
Inventor
Valter D. Longo
Chia-Wei Cheng
Sebastian BRANDHORST
Min Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of CA2888811A1 publication Critical patent/CA2888811A1/en
Application granted granted Critical
Publication of CA2888811C publication Critical patent/CA2888811C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2888811A 2012-10-22 2013-10-22 A diet package, and uses thereof Active CA2888811C (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261716676P 2012-10-22 2012-10-22
US61/716,676 2012-10-22
US201261736308P 2012-12-12 2012-12-12
US61/736,308 2012-12-12
US201261746787P 2012-12-28 2012-12-28
US61/746,787 2012-12-28
PCT/US2013/066236 WO2014066426A1 (en) 2012-10-22 2013-10-22 Methods and formulations promoting tissue/organ regeneration, longevity and healthspan

Publications (2)

Publication Number Publication Date
CA2888811A1 CA2888811A1 (en) 2014-05-01
CA2888811C true CA2888811C (en) 2023-10-24

Family

ID=50485540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2888811A Active CA2888811C (en) 2012-10-22 2013-10-22 A diet package, and uses thereof

Country Status (6)

Country Link
US (3) US10015980B2 (cg-RX-API-DMAC7.html)
EP (1) EP2909802B1 (cg-RX-API-DMAC7.html)
JP (3) JP6325555B2 (cg-RX-API-DMAC7.html)
CA (1) CA2888811C (cg-RX-API-DMAC7.html)
ES (1) ES2822178T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014066426A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10015980B2 (en) 2012-10-22 2018-07-10 University Of Southern California Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
KR20150124962A (ko) * 2013-02-12 2015-11-06 유니버시티 오브 써던 캘리포니아 화학 독성 및 연령 관련 질병으로부터 보호하기 위한 방법 및 규정식
WO2015002972A1 (en) 2013-07-01 2015-01-08 University Of Southern California Fasting condition as dietary treatment of diabetes
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
WO2015153850A2 (en) * 2014-04-02 2015-10-08 University Of Southern California Autoimmunity and multiple sclerosis treatment
US11000057B2 (en) * 2015-05-06 2021-05-11 University Of Southern California Fasting mimicking and enhancing diet for treating hypertension and lipid disorders
BR112018014069A2 (pt) * 2016-01-12 2018-12-11 Univ Southern California uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.
ES2970314T3 (es) 2016-02-15 2024-05-28 Univ Southern California Combinaciones de fármacos y métodos para estimular una regeneración similar a la embrionaria para tratar la diabetes
EP3454867B1 (en) * 2016-05-11 2021-03-24 University of Southern California Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases
IT201700008499A1 (it) 2017-01-26 2018-07-26 Univ Degli Studi Genova Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
US11284640B2 (en) * 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
MX2020002670A (es) * 2017-09-12 2020-07-20 Nestle Sa Metodos para imitar la restriccion calorica cronica y para impartir beneficios de salud a un animal.
KR20200125966A (ko) * 2018-03-15 2020-11-05 유니버시티 오브 써던 캘리포니아 염증 및 ibd 병리의 역전을 촉진하는, 물만 섭취하는 금식이 아닌 금식 모방 식이요법 (fmd)
US20210267250A1 (en) 2018-07-18 2021-09-02 Andreas Michalsen Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer
KR20210113161A (ko) 2018-11-09 2021-09-15 엘-뉴트라 인코포레이티드 간헐적 단식-모방을 위한 영양 바
US12185747B2 (en) 2019-04-30 2025-01-07 University Of Southern California Fasting-mimicking diet (FMD) as an intervention for Alzheimer's disease (AD)
IT202000008740A1 (it) 2020-04-23 2021-10-23 L Nutra Inc Composizione dietetica per l’incremento della massa magra e della massa muscolare
IT202000016957A1 (it) 2020-07-13 2022-01-13 Univ Degli Studi Di Palermo Composizione dietetica per il trattamento della depressione
JP7727286B2 (ja) * 2020-09-23 2025-08-21 アミノヴィタ エセ．エレ． 癌の代謝療法
TW202227113A (zh) 2020-12-01 2022-07-16 南加州州立大學 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活
TW202236983A (zh) * 2020-12-03 2022-10-01 南加州州立大學 提升骨骼肌再生及強度的模擬禁食生酮飲食(fmd)
US20220175007A1 (en) * 2020-12-09 2022-06-09 University Of Southern California Fasting mimicking ketogenic diet to improve immune function and vaccine response and minimize risk in adults and elderly
US20250177466A1 (en) * 2022-08-23 2025-06-05 University Of Southern California Dietary compositions to extend longevity while maximizing strength and function

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356252A (en) * 1970-03-25 1974-06-12 Briggs J H Pryor J S Fryers G Dietetic foodstuffs
JP2004518647A (ja) * 2000-12-15 2004-06-24 ナチュラルエンド テック カンパニー リミテッド インシュリン様成長因子−１の分泌誘導用薬剤学的組成物および食品組成物
US20020106308A1 (en) 2001-02-02 2002-08-08 Zweifel Ronald A. Microdrop dispensing apparatus
US8821915B2 (en) * 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
US20070116802A1 (en) * 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
MX2009006466A (es) 2006-12-13 2009-06-26 Schering Corp Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
WO2008119077A1 (en) 2007-03-28 2008-10-02 University Of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
BRPI0819759A2 (pt) * 2007-11-26 2015-05-05 Nestec Sa Composições e métodos para inibir a ativação da proteína quinase dependente de ds-rna e inibição de crescimento de tumor
EP2381774A4 (en) * 2008-12-23 2012-07-18 Salk Inst For Biological Studi METHOD FOR TREATING NEURODEEGENERATIVE ILLNESSES
RU2549954C2 (ru) * 2009-10-22 2015-05-10 Юниверсити Оф Саутерн Калифорния Способы и диетологические составы для повышения эффективности и снижения побочных эффектов лечения рака
US20130045215A1 (en) 2010-04-28 2013-02-21 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
WO2012109353A2 (en) * 2011-02-08 2012-08-16 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
WO2012113415A1 (en) * 2011-02-24 2012-08-30 N.V. Nutricia Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
US10015980B2 (en) 2012-10-22 2018-07-10 University Of Southern California Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
KR20150124962A (ko) * 2013-02-12 2015-11-06 유니버시티 오브 써던 캘리포니아 화학 독성 및 연령 관련 질병으로부터 보호하기 위한 방법 및 규정식

Also Published As

Publication number Publication date
WO2014066426A1 (en) 2014-05-01
EP2909802A1 (en) 2015-08-26
CA2888811A1 (en) 2014-05-01
JP2018140989A (ja) 2018-09-13
JP6325555B2 (ja) 2018-05-16
US20210177032A1 (en) 2021-06-17
EP2909802A4 (en) 2016-11-02
US20170035093A1 (en) 2017-02-09
US20140112909A1 (en) 2014-04-24
ES2822178T3 (es) 2021-04-29
JP2016505804A (ja) 2016-02-25
US12484607B2 (en) 2025-12-02
JP2021061849A (ja) 2021-04-22
EP2909802B1 (en) 2020-08-12
US10015980B2 (en) 2018-07-10
HK1211723A1 (en) 2016-05-27

Similar Documents

Publication Publication Date Title
US12484607B2 (en) Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
CN109187991B (zh) 为受试者提供合理蛋白质膳食的方法
EP2317878B1 (en) Nutritional composition for improving muscle function and daily activity
TW201134470A (en) Anaplerotic therapy for Alzheimer's disease and the aging brain
Yuen et al. An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy
Paoli et al. Not only protein: dietary supplements to optimize the skeletal muscle growth response to resistance training: the current state of knowledge
JP2021183622A (ja) 多発性骨髄腫及び他のがんに対する食事療法としての長期断食模倣の使用
CN118900686A (zh) 增强一种或多种合成代谢氨基酸对骨健康的肌肉骨骼效应的组合物和方法
Garibotto et al. How to overcome anabolic resistance in dialysis-treated patients?
HK1211723B (en) Diet formulations promoting tissue/organ regeneration
Morley Lochs H, Thomas DR (eds): Home Care Enteral Feeding. Nestlé Nutrition Workshop Series Clinical & Performance Program, vol 10, pp 167–178, Nestec Ltd., Vevey/S. Karger AG, Basel,© 2005.
Kaur et al. Can thyalakoids replace bariatric surgery for long term maintenance of weight loss in obesity giving a more physiological approach
Jaffe Phytonutrients in diabetes management
Yamanaka-Okumura et al. Treatment of rapid weight loss in a donor with hepatic steatosis in living donor liver transplantation: A case report
Solis et al. Potential of Creatine in Glucose Management and Diabetes. Nutrients 2021, 13, 570
HK40002950A (en) Method for providing reasonable protein diet to subject
Tamirci et al. Energy Balance and Management in Sports and Exercise
EP4565324A1 (en) Vitamin a-free nutritional compositions for treating dysfunction of liver fat metabolism
Yonke Branched-Chain Amino Acid Metabolism in the Neonatal Pig
Markus Effects of Breakfast Dietary Protein Source and Level on Satiety
Williams Taurine, the Benefits for Heart, Vision and Energy
Kondrup 22 Nutrition in End-Stage
CANDOW RALPH J. MANDERS, JONATHAN P. LITTLE, SCOTT C. FORBES, AND DARREN G. CANDOW
HK1212028B (en) Methods and diets to protect against chemotoxicity and age related illnesses
Wei The Impact of Vitamin A Supplementation in the Early Postnatal Period on Metabolic Regulation Related to Childhood Obesity Risk

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002

EEER Examination request

Effective date: 20181002